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Abstract Circulating monocytes in human peripheral blood are 
readily available, easily obtained, and can be cultured in vitro. 
Once plated, the monocytes spontaneously differentiate into 
macrophages. Undifferentiated human monocytes do not express 
carboxypeptidase E (CPE), prohormone convertase 3 (PC3/ 
PCI) or proenkephalin (ENK), suggesting that gene induction 
during differentiation results in the expression of these genes. 
RT-PCR of human monocyte-derived macrophage (HMDM) 
mRNA showed detectable levels of ENK mRNA at 48 h after 
plating, followed by PC3 and CPE mRNAs at 72 h. PC3 
expression was confirmed by Western blotting in THP-1 cells. 
Similarities in expression of enzymes involved in the conversion 
of neuroendocrine precursors, such as proenkephalin, into 
functionally mature peptides underscores the close association 
HMDMs may share with the neuroendocrine system. Because of 
this, H M D M s may prove to be a valuable, non-surgical source of 
human tissue for clinical genetic diagnosis of some convertase 
disorders. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The prohormone convertases, PC3/PC1 and PC2 are the 
preeminent neuroendocrine convertases of the subtilisin-like 
proprotein convertase (SPC) family and are believed to proc-
ess a wide variety of neuroendocrine and hormone precursors 
in the brain and endocrine systems. Both PC2 and PC3 have 
been shown to be involved in the post-translational processing 
of proinsulin in the islets of Langerhans [1,2], in the differ-
ential processing of proglucagon in the islets versus intestine 
[3] and proopiomelanocortin in the anterior versus intermedi-
ate lobes of the hypophysis [4,5]. Carboxypeptidase E (CPE) 
is an exopeptidase capable of removing the C-terminal argi-
nine residues remaining after endoproteolytic cleavage of var-
ious precursors. Recent studies have directed attention to-
wards syndromes arising from defects in these processing 
enzymes. The obesity and hyperglycaemia observed in the 
fat/fat mouse are a consequence of a mutat ion in the CPE 
gene [6]. A deficiency in PC3 activity has been proposed to 
be the causitive agent responsible for a unique form of hyper-
proinsulinemia in a human subject [7], and may also be re-
lated to the elevated proinsulin levels associated with Type 2 
diabetes [8]. The reported presence of PC2 in rat polymorpho-
nuclear leukocytes and alveolar macrophages and PC3 in rat 
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alveolar and splenic macrophages [9] led us to hypothesize the 
existence of these enzymes in human monocyte-derived mac-
rophages ( H M D M ) and in the human monocytic leukemia 
cell line THP-1 as well. Accordingly, we have investigated 
the expression of PC3, PC2, CPE and enkephalin (ENK) 
m R N A s by RT -PCR in H M D M s and in THP-1 cells and 
have examined whether these enzymes are induced during 
normal human monocytic differentiation in vitro. The results 
indicate that H M D M s may be a previously unexploited 
source of human tissue for clinical genetic diagnosis of hor-
monal processing defects in man because of their partial en-
zymatic similarities with the neuroendocrine system. 
2. Materials and methods 
2.1. Amplification of PC2, PC3, CPE and ENK 
THP-1 mRNA from 1X107 cells/time point and HMDM mRNA 
from 5X106 cells/time point was prepared using QuickPrep Micro 
mRNA purification kit (Pharmacia Biotech). All mRNA obtained 
were immediately converted into cDNA using Superscript Preamplifi-
cation System (Life Technologies). RT-PCR reactions employed Elon-
gase (Life Technologies) and HotStart 50 tubes (M(3P). Each reaction 
was denatured at 94°C for 1 min 30 s, amplified 30 cycles at 94°C for 
30 s, 55°C for 30 s, and 68°C for 45 s to 1 min 15 s depending on the 
target size. Amplification primers used were: PC2 5'-GACCGGTCT-
TCACGAATCAT and PC2 3'-CCGTAGCCAAAGAGGTGATT; 
PC3 5'-TGACCTGCACAATGACTGCA and PC3 3'-TGCACTTG-
GGGACTTCTTTG; CPE 5'-TCAGCAGGATTTACACGGTG and 
CPE 3'-GCTGTAAGGAACTGCCACTT; ENK 5'-ACATCAACT-
TCCTGGCTTGC and ENK 3'-CACCATCAACAGTTTCCCAC. 
PCR reactions were analyzed on a 1% agarose gel, 1 X TBE [10]. 
2.2. Preparation and cycle sequencing of PC3, CPE and ENK DNA 
DNA bands for PC3, CPE and ENK were excized from 1% agarose 
gels, placed in 1.5 ml EpendorfT tubes containing 200 al of sterile 
water and frozen at —20°C overnight. The tubes were then thawed, 
the contents transferred to Ultrafree-MC filter units (Millipore) and 
centrifuged for 10 min, 10K rpm, 25°C. The filtrates were ammonium 
acetate/ethanol precipitated [11] overnight at —20°C using 1 ul of 10 
mg/ml glycogen (Boehringer-Mannheim) as carrier. The DNAs were 
pelleted by centrifugation for 30 min, 14K rpm, 25°C. The ethanol 
was aspirated, the pellets were washed 1 X with cold 70% ethanol and 
dried for 2 min in a SpeedVac. Each pellet was dissolved in 10 ul of 
sterile water. Analysis by cycle sequencing was performed on 5 ul of 
each sample using SequiTherm (Epicentre Technologies), and 33P-
ATP end-labelled internal sequencing primers. 
2.3. Isolation of human monocytes from peripheral blood 
Blood samples were obtained from normal human volunteers, and 
monocytes prepared as previously described [12], by drawing one 15 
ml Sodium Heparin Vacutainer Tube (A - monocytes) and 1-15 ml 
SST Gel and Clot Activator Vacutainer Tube (B - human serum). The 
contents of Tube A were transferred to a 50 ml conical tube and 
diluted with 25 ml of 0.9% NaCl/1 mM EDTA solution. Four milli-
liters of Ficoll-Paque Gradient (Pharmacia Biotech) were pipetted into 
4-15 ml conical tubes and 10 ml of diluted blood solution layered on 
top. The tubes were centrifuged at 1500 rpm in a 20°C refrigerated 
table-top centrifuge, 20 min, without brake, and the serum aspirated 
from the gradient. White blood cells (WBC) from each of the four 
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Fig. 1. RT-PCR analysis of PC3 and PC2 mRNA expression in THP-1 cells. Messenger RNA from 1X 107 THP-1 cells was isolated at 0, 24, 
48, 72, and 96 h after treatment with 400 ng/ml PMA (Sigma). The 969 bp band corresponding to PC3 is visible at 48, 72 and 96 h. PC2 is un-
detectable throughout the time course. Water was used as a negative control. A plasmid containing the complete coding region of PC2 cDNA 
was used as template for the positive control. 
gradients were collected, transferred to 1-50 ml conical tube and the 
volume brought to 50 ml with 0.9% NaCl solution. The WBCs were 
centrifuged at 1200 rpm, 8 min, 20°C with brake and the cell pellet 
washed 1 X with 10 ml of RPMI-1640/1% Pen-Strep (Life Technolo-
gies). The WBCs were centrifuged at 1200 rpm, 8 min, 20°C with 
brake, resuspended in 10 ml of RPMI-1640/1% Pen-Strep and 
counted. WBCs were diluted to 5X106 cells/ml with RPMI-1640/1% 
Pen-Strep/10% NHS (normal human serum). WBCs were plated in 
6 cm tissue culture dishes (Corning), gently roughened with a braided 
wire brush and incubated at 37°C for 1 h to allow the monocytes to 
adhere to the tissue culture plate surface. The medium was removed 
and replaced with 5 ml of fresh RPMI-1640/1% Pen-Strep/10% NHS. 
2.4. Immunoblotting 
Secretory granule enriched fractions were prepared from THP-1 
cells by homogenization in 0.275 M sucrose as previously described 
[13]. Samples were run on a 7.5% SDS-PAGE gel [14] and transferred 
by Western blotting [15] onto an Immobilon-P membrane (Millipore). 
The membrane was blocked (5% non-fat dried milk, 1 X PBS, 0.2% 
Tween-20), incubated overnight with a 1:1000 dilution of RS20 PC3 
antibody [13], and the immunoreactive bands visualized using ECL 
(Amersham). 
3. Results 
3.1. RT-PCR of THP-1 mRNA shows expression of hPC3, 
hCPE, and hENK 
THP-1 cells were obtained directly from suspension, or cul-
tured in media containing PMA, and allowed to differentiate 
into macrophages for 24, 48, 72 and 96 h. The mRNA was 
then isolated and subjected to RT-PCR analysis to identify 
the presence of hPC2 [16], hPC3 [17], hCPE [18] or hENK [19] 
transcripts. Primer pairs were designed to generate amplified 
fragments of a unique size (PC2, 1255 bp; CPE, 1102 bp; 
PC3, 969 bp; and ENK, 752 bp). Amplification of PC2 and 
PC3 were done simultaneously and run on the same agarose 
gel. The only band identifiable as PC2 is in the positive con-
trol lane (Fig. 1, lane 13). The adjacent PC3 amplification 
reveals bands at 48, 72, and 96 h (Fig. 1, lanes 3-5). Bands 
of the appropriate size for CPE (Fig. 2a, lanes 1-5) and ENK 
(Fig. 2b, lanes 1-5) were observed in all lanes during the 96 h 
time course. 
and 5). Southern Blot analysis of the same gel revealed the 
complete absence of any signal prior to 72 h (Fig. 3b, lanes 1-
3). CPE expression is identical to that of PC3 with the first 
appearance of the CPE transcript at 72 h (Fig. 4a, lane 4). A 
752 bp band corresponding to ENK is observable at 48-96 h 
(Fig. 4b, lanes 3-5). 
3.3. Western analysis and immunoprecipitation of PC3 protein 
in THP-1 cells 
A granule rich fraction was prepared from THP-1 cells 
grown in PMA-treated and PMAAE. coli lipopolysaccharide 
(LPS)-treated media for 96 h. Two different amounts of sam-
ple (6 and 12.5 ug) were electrophoresed in adjacent lanes, for 
both conditions, on an SDS gel and Western blotted using the 
anti-PC3 antibody RS20. The lanes containing only 6 u.g of 
sample (Fig. 5, lanes 1 and 3) showed the presence of a single 
66 kDa band corresponding to the C-terminally processed 
form of PC3. The lanes containing 12.5 ug of sample (Fig. 
5, lanes 2 and 4) showed a very prominent band at 66 kDa in 
addition to a second, less prominent band at 87 kDa [20]. The 
higher molecular weight band corresponds to the unprocessed 
form of PC3. Both forms of PC3 were also identified by pulse-
chase labelling and immunoprecipitation in HMDMs (data 
not shown). 
3.2. RT-PCR of HMDM mRNA shows expression of hPC3, 
hCPE, and hENK 
Human monocytes were plated and grown in culture for 0, 
24, 48, 72 and 96 h. HMDM mRNA was isolated for each 
time point and subjected to RT-PCR analysis to identify the 
presence of PC2, PC3, CPE, or ENK transcripts. Amplifica-
tion of PC3 showed the presence of an appropriate size band 
of 969 bp after 72 and 96 h of differentiation (Fig. 3a, lanes 4 
Fig. 2. RT-PCR analysis of CPE and ENK mRNA expression in 
THP-1 cells. Messenger RNA from 1X 107 THP-1 cells was isolated 
at 0, 24, 48, 72, and 96 h after treatment with PMA. a: The 1102 
bp amplification product corresponding to CPE is visible at 0 h in 
untreated THP-1 cells and is markedly increased at 24, 48, 72 and 
96 h. b: The 752 bp amplification product corresponding to ENK is 
prominent at all time points during the 96 h time course. 
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Fig. 3. RT-PCR analysis of PC3 mRNA expression in HMDM. a: cDNA from 0, 24, 48, 72, and 96 h was amplified by PCR. The DNA 
band corresponding to PC3 can be seen at 72 and 96 h. Lane 6 represents a positive control for PC3 from THP-1 cDNA. Lane 7 is a negative 
water control, b: The gel was transferred by Southern blotting onto a GeneScreen Plus Membrane. The filter was probed with a 33P end-la-
belled, 40-mer oligonucleotide corresponding to bases 1468-1508 of the human PC3 DNA sequence. 
Fig. 4. RT-PCR analysis of CPE and ENK mRNA expression in HMDMs. Messenger RNA was obtained from 5x 106 HMDMs at 0, 24, 48, 
72, and 96 h after plating, a: The DNA band corresponding to CPE can be seen at 72 and 96 h. Lanes 6 and 7 are positive THP-1 controls 
for CPE. Lane 8 is a negative water control, b: The DNA band to corresponding to ENK can be seen at 48, 72 and 96 h. Lane 6 is a positive 
control for ENK using cDNA from 96 h THP-1 cells. Lane 7 is a negative water control. 
4. Discussion 
PC3, CPE and ENK mRNA were detected in differentiated 
THP-1 cells and differentiated HMDMs by RT-PCR. Expres-
sion of CPE, ENK and PC3 mRNA appear to be the result of 
either gene induction or derepression during differentiation in 
respect to HMDMs. The transcription of PC3 and CPE 
mRNA in HMDMs occurs simultaneously, is first evident 
72 h after plating and is preceded by ENK mRNA which 
can be detected by 48 h. Western blot analysis of THP-1 cells 
confirmed the presence of both the 87 kDa (unprocessed), and 
the 66 kDa (C-terminally processed) forms of PC3 in the 
granule fraction. The THP-1 cell line may differ somewhat 
in the temporal aspects of induction of PC3, CPE, and 
ENK but was congruous with HMDM mRNA expression 
with regard to the lack of PC2 expression, adding further 
evidence that THP-1 cells are a useful model of macrophage 
differentiation [21]. 
Single-stranded conformational polymorphism (SSCP) is a 
powerful method of mutational analysis [22]. A common 
source of human genomic DNA, which is used as template 
for SSCP, is from blood samples and can be purified by stand-
ard methods [23] or by use of a variety of commercially avail-
able kits. SSCP can detect DNA point mutations after ampli-
fication of the target DNA with radiolabelled oligonucleotide 
primers. A shift in electrophoretic mobility on a polyacryl-
amide-urea gel can be seen following autoradiography. This 
method is limited by resolution, which is dependent on the 
size of the DNA fragment(s) used for electrophoresis. 
Genetic analysis, for the purpose of medical diagnosis of 
disorders involving PC3 [7,8], CPE [24] or more complex 
genes, like the sulfonylurea receptor [25], requires complete 
knowledge of the genomic organization of the suspected cul-
prit gene so that each exon can be properly amplified. If the 
genomic organization is unknown, as is the case for hCPE, 
SSCP becomes technically impossible or is at best a guessing 
game based on gene organization inferred from that of other 
species. The use of HMDMs for PC3 and CPE analysis cir-
cumvents this problem. The flexibility of the system is an 
advantage not possessed by conventional SSCP protocols. 
Any mRNA which is expressed in monocytes or differentiated 
macrophages can be converted to cDNA and analyzed indi-
rectly by SSCP. There are no intron sequences to avoid, so 
primers can be designed anywhere along the coding sequence 
to generate fragments of optimal length for analysis. The 
cDNA can also be analyzed directly by manual or automated 
cycle sequencing methods. 
It has been proposed that PC3 could be used as a marker 
for neuroendocrine differentiation [13], because PC3 expres-
sion has been confined to representatives of this family of 
tissues [26,27]. In addition to their medical value as a source 
Fig. 5. Detection of PC3 protein in THP-1 cells and HMDMs. Se-
cretory granule enriched cell extracts were prepared from THP-1 
cells grown for 96 h in PMA-treated RPMI-1640 media or PMA-
treated media supplemented with E. coli 055:B5 LPS (Difco) for the 
final 24 h. Immunoblotting revealed the presence of the 66 kDa 
form of PC3 visible as the lower band in all four lanes. The 87 kDa 
form of PC3 is also visible in lanes 2 and 4. 
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of information for genetic analysis, H M D M s possess addi-
tional attributes which enhance their value as an investigatory 
tool. Transcription of E N K m R N A , immunoreactivity to 
met -ENK peptide [28], secretion of me t -ENK by monocytes 
and the PC3 marker, suggest an alternate function of 
H M D M s as a previously unrecognized neuroendocrine 
source. 
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